Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Buy
73
HTGC Quote, Financials, Valuation and Earnings
Last price:
$19.42
Seasonality move
:
0.83%
Day range:
$18.87 - $19.22
52-week range:
$15.65 - $22.04
Dividend yield:
9.89%
P/E ratio:
14.45x
P/S ratio:
10.27x
P/B ratio:
1.69x
Volume:
932.3K
Avg. volume:
945.3K
1-year change:
-10.31%
Market cap:
$3.4B
Revenue:
$353.7M
EPS (TTM):
$1.33
Analysts' Opinion
-
Consensus RatingHercules Capital has received a consensus rating of Buy. The company's average rating is a Buy based on 3 Buy ratings, 2 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $20.69, Hercules Capital has an estimated upside of 7.64% from its current price of $19.22.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $18.00 representing 6.35% downside risk from its current price of $19.22.
Fair Value
-
According to the consensus of 5 analysts, Hercules Capital has 7.64% upside to fair value with a price target of $20.69 per share.
HTGC vs. S&P 500
-
Over the past 5 trading days, Hercules Capital has overperformed the S&P 500 by 3.49% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
Hercules Capital does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Hercules Capital revenues have been falling on a year-over-year basis for 2 quarters in a row. In the most recent quarter Hercules Capital reported revenues of $72.7M.
Earnings Growth
-
Hercules Capital earnings have been falling on a year-over-year basis for 2 quarters in a row. In the most recent quarter Hercules Capital reported earnings per share of $0.29.
Enterprise value:
5.3B
EV / Invested capital:
--
Price / LTM sales:
10.27x
EV / EBIT:
17.62x
EV / Revenue:
17.10x
PEG ratio (5yr expected):
10.53x
EV / Free cash flow:
-53.24x
Price / Operating cash flow:
82.51x
Enterprise value / EBITDA:
--
Gross Profit (TTM):
--
Return On Assets:
5.89%
Net Income Margin (TTM):
71.56%
Return On Equity:
11.6%
Return On Invested Capital:
5.96%
Operating Margin:
--
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Income Statement | ||||||
| Revenue | $284.1M | $424.7M | $310.7M | $115.7M | $72.7M | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Operating Income | -- | -- | -- | -- | -- | |
| EBITDA | -- | -- | -- | -- | -- | |
| Diluted EPS | $1.47 | $2.20 | $1.33 | $0.57 | $0.29 | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $95.6M | $79M | $102.6M | $85.6M | $84.3M | |
| Total Assets | $2.6B | $2.7B | $3.3B | $3.7B | $4B | |
| Current Liabilities | $28.3M | $27.2M | $33.4M | $38.7M | $36.7M | |
| Total Liabilities | $1.3B | $1.4B | $1.8B | $1.8B | $2B | |
| Total Equity | $1.3B | $1.3B | $1.5B | $1.9B | $2B | |
| Total Debt | $1.2B | $1.3B | $1.7B | $1.8B | $2B | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -$317.1M | -$91.7M | -$99.4M | -$240.9M | -$222.2M | |
| Cash From Investing | -$158K | -$1.1M | -$421K | -$292K | -$8K | |
| Cash From Financing | $333.7M | $74.2M | $93.9M | $185.5M | $160.1M | |
| Free Cash Flow | -$317.2M | -$92.8M | -$99.8M | -$241.2M | -$222.2M | |
HTGC
Sector
Market Cap
$3.4B
$627.9M
Price % of 52-Week High
87.21%
89.42%
Dividend Yield
9.89%
1.97%
Shareholder Yield
1.64%
4.06%
1-Year Price Total Return
-10.31%
7.77%
Beta (5-Year)
0.937
0.585
Dividend yield:
9.89%
Annualized payout:
$1.92
Payout ratio:
138.57%
Growth streak:
1 years
Technicals
8-day SMA
Buy
Level
$18.80
200-day SMA
Buy
Level
$19.11
Bollinger Bands (100)
Buy
Level
17.25 - 19.43
Chaikin Money Flow
Buy
Level
2.2M
20-day SMA
Buy
Level
$18.41
Relative Strength Index (RSI14)
Buy
Level
74.60
ADX Line
Buy
Level
34.08
Williams %R
Sell
Level
0
50-day SMA
Buy
Level
$17.99
MACD (12, 26)
Buy
Level
5.18
25-day Aroon Oscillator
Buy
Level
64
On Balance Volume
Neutral
Level
6.6M
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (1.5624)
Buy
CA Score
(Annual)
Level (0.1019)
--
Beneish M-Score
(Annual)
Level (--)
Sell
Momentum Score
Level (5)
Buy
Ohlson Score
Level (-0.291)
--
Piotroski F Score
(Annual)
Level (--)
--
Quality Ratio Score
Level (--)
Buy
Fundamental Score
Level (8)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Hercules Capital Inc is a specialty finance company that provides senior secured loans to high-growth, venture capital-backed companies in various technology, life sciences, and sustainable and renewable technology industries. It invests majorly in structured debt with warrants and, to a lesser extent, in senior debt and equity investments. The company lends to and invests in portfolio companies in various technology-related industries, including technology, drug discovery and development, biotechnology, life sciences, healthcare, and sustainable and renewable technology.
Stock Forecast FAQ
In the current month, HTGC has received 3 Buy ratings 2 Hold ratings, and 0 Sell ratings. The HTGC average analyst price target in the past 3 months is $20.69.
-
Where Will Hercules Capital Stock Be In 1 Year?
According to analysts, the consensus estimate is that Hercules Capital share price will rise to $20.69 per share over the next 12 months.
-
What Do Analysts Say About Hercules Capital?
Analysts are divided on their view about Hercules Capital share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Hercules Capital is a Sell and believe this share price will drop from its current level to $18.00.
-
What Is Hercules Capital's Price Target?
The price target for Hercules Capital over the next 1-year time period is forecast to be $20.69 according to 5 Wall Street analysts, 3 of them rate the stock a Buy, 0 rate the stock a Sell, and 2 analysts rate the stock a Hold.
-
Is HTGC A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Hercules Capital is a Buy. 3 of 5 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of HTGC?
You can purchase shares of Hercules Capital via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Hercules Capital shares.
-
What Is The Hercules Capital Share Price Today?
Hercules Capital was last trading at $19.42 per share. This represents the most recent stock quote for Hercules Capital. Yesterday, Hercules Capital closed at $19.22 per share.
-
How To Buy Hercules Capital Stock Online?
In order to purchase Hercules Capital stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
70
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 58x
Buy
62
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
82
SBET alert for Jul 17
SharpLink Gaming [SBET] is down 2.6% over the past day.
Buy
89
EXOD alert for Jul 17
Exodus Movement [EXOD] is down 4.14% over the past day.
Buy
60
U alert for Jul 17
Unity Software [U] is up 7.51% over the past day.
